UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (415) 415
life sciences & biomedicine (399) 399
humans (325) 325
cardiovascular system & cardiology (293) 293
cardiac & cardiovascular systems (286) 286
female (272) 272
male (272) 272
aged (241) 241
middle aged (234) 234
heart failure (173) 173
mortality (128) 128
risk factors (128) 128
prognosis (110) 110
aged, 80 and over (95) 95
abridged index medicus (90) 90
adult (79) 79
follow-up studies (69) 69
myocardial infarction (63) 63
denmark - epidemiology (62) 62
heart failure - physiopathology (59) 59
heart attacks (58) 58
heart failure - mortality (58) 58
cardiology (56) 56
proportional hazards models (55) 55
time factors (52) 52
heart failure - drug therapy (50) 50
treatment outcome (50) 50
analysis (49) 49
care and treatment (49) 49
diabetes (48) 48
myocardial infarction - complications (48) 48
myocardial infarction - mortality (48) 48
patients (47) 47
general & internal medicine (46) 46
heart attack (45) 45
research (45) 45
cardiovascular diseases (44) 44
denmark (44) 44
double-blind method (44) 44
prospective studies (44) 44
risk assessment (44) 44
cardiac and cardiovascular systems (41) 41
kardiologi (41) 41
comorbidity (40) 40
epidemiology (40) 40
heart diseases (40) 40
patient outcomes (40) 40
cardiovascular (39) 39
medicine, general & internal (39) 39
cardiovascular disease (38) 38
retrospective studies (38) 38
atrial fibrillation (37) 37
cardiac patients (37) 37
drug therapy (37) 37
registries (36) 36
studies (36) 36
cohort studies (34) 34
electrocardiography (34) 34
heart (33) 33
incidence (33) 33
myocardial infarction - drug therapy (33) 33
stroke (33) 33
myocardial infarction - physiopathology (32) 32
cardiac arrhythmia (31) 31
clinical medicine (31) 31
clinical trials (31) 31
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (31) 31
risk (31) 31
echocardiography (29) 29
klinisk medicin (29) 29
stroke volume (29) 29
diabetes mellitus (28) 28
hospitalization (28) 28
hypertension (28) 28
peripheral vascular disease (28) 28
predictive value of tests (28) 28
survival analysis (28) 28
health aspects (27) 27
heart failure - epidemiology (27) 27
angiotensin-converting enzyme inhibitors - therapeutic use (26) 26
health risk assessment (26) 26
ventricular dysfunction, left - physiopathology (26) 26
kaplan-meier estimate (25) 25
endocrinology & metabolism (24) 24
hospitals (24) 24
radiology, nuclear medicine & medical imaging (24) 24
randomized controlled trials as topic (24) 24
research article (24) 24
usage (24) 24
acute myocardial infarction (23) 23
heart failure - complications (23) 23
heart failure - diagnosis (23) 23
medical research (23) 23
blood pressure (22) 22
medicine, experimental (22) 22
multivariate analysis (22) 22
stroke volume - physiology (22) 22
complications and side effects (21) 21
medical and health sciences (21) 21
medicin och hälsovetenskap (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2016, Volume 374, Issue 16, pp. 1521 - 1532
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 1, pp. 41 - 51
Journal Article
European heart journal, ISSN 1522-9645, 05/2012, Volume 33, Issue 14, pp. 1787 - 1847
Journal Article